CD274 and breast cancer: Although higher G2M and E2F targets scores had been associated with a greater PD-L1 expression in NSCLC [31], the G2M checkpoint activation in pancreatic and breast cancer was linked to Th2 response [32,33], which is typically associated with the promotion of tumor growth and the repression of anti-tumor immunity.